Drug and pharmaceutical recalls

346 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.

Recent recalls

Page 10 of 12
  • First Aid Only and Med-Nap BZK wipes recalled for manufacturing deviations

    Acme United Corporation is recalling 21 antiseptic and hand sanitizing towelette and wipe products nationwide for manufacturing (CGMP) deviations, a Class II classification. The products are sold under names including First Aid Only, Med-Nap, Dukal, Dynarex, Piedmont Sanitizing, Max Packaging, Savannah, Medi-First, Wipes Plus, WP WipesPlus, Green Guard, and Children's Healthcare of Atlanta, among others. No injuries have been reported.

    ModerateFDAMar 11, 2026Acme21 products

  • Teva metoprolol succinate tablets recalled for dissolution failure

    Teva is recalling four strengths of metoprolol succinate extended-release tablets (25 mg, 50 mg, 100 mg and 200 mg), sold in 100- and 1,000-tablet bottles. The tablets did not meet the required dissolution specification, which means they may not release the medicine at the expected rate. No injuries have been reported.

    ModerateFDAMar 11, 2026Teva4 products

  • Vista, Bio Glo and CHNaO eye products recalled for sterility

    Wizcure Pharma is recalling seven eye products sold nationwide: Vista dry eye drops (Vista Tears, Vista Gel, Vista Meibo Tears and Vista Gonio), Bio Glo and BioGlo fluorescein diagnostic test strips, and CHNaO fluorescein test strips. The FDA says the products were not made under current good manufacturing practices, so the company cannot assure they are sterile. No injuries have been reported.

    ModerateFDAMar 4, 2026Wizcure Pharma7 products

  • Agebox iKids-Growth supplements recalled for undeclared ibutamoren

    The FDA says Agebox iKids-Growth capsules contain ibutamoren, an ingredient that is not listed on the label and is not approved for use in these products. The recall covers two products, both sold as 60-count bottles of Agebox iKids-Growth capsules: a Day Formula and a Night Formula. No injuries have been reported.

    ModerateFDAMar 4, 2026Agebox2 products

  • Check Slate Run Eptifibatide Injection labeling

    Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.

    ModerateFDAMar 4, 2026Slate Run Pharmaceuticals

  • Stop using AvKARE Amantadine HCl capsules

    AvKARE is recalling one lot of Amantadine HCl 100 mg capsules because they failed to meet dissolution specifications—meaning the capsules may not break down properly in the body, affecting how much medicine you receive. This is a quality issue identified during manufacturing testing. No injuries have been reported.

    ModerateFDAMar 4, 2026AvKARE

  • Stop using recalled Adbry injection lots

    LEO Pharma is recalling specific lots of Adbry, a prescription injection used to treat atopic dermatitis, because one unit was found to contain wool fiber particles. This contamination raises concerns about sterility and safety. No injuries have been reported so far.

    ModerateFDAMar 4, 2026Leo Pharma

  • UDENYCA pegfilgrastim syringes recalled for improper storage

    McKesson's UDENYCA (pegfilgrastim-cbqv) injection was stored at room temperature instead of in the refrigerator, which may have reduced its effectiveness. This affected 116 cartons from Lot 2199821 with specific serial numbers. The FDA classified this as a Class I recall.

    SeriousFDAFeb 18, 2026McKesson

  • Stop using Meitheal Cetrorelix Acetate injection kits

    Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.

    ModerateFDAFeb 18, 2026Meitheal Pharmaceuticals

  • American Health Packaging oxycodone recalled for blister seal defects

    American Health Packaging is recalling certain oxycodone hydrochloride 5 mg tablets because the blister card seals are defective or missing. This allows tablets to fall out of their compartments. The recall affects 31,676 packages distributed nationwide with specific lot numbers and expiration dates.

    ModerateFDAFeb 18, 2026Amerisource

  • Fagron Sterile Services IV bags recalled over sterility concerns

    Fresenius Kabi is recalling five premixed IV bags labeled Fagron Sterile Services in Canton, MA: acyclovir, ketamine, thiamine, and two strengths of vancomycin. The company cannot assure the bags are sterile. No injuries have been reported.

    SeriousFDAFeb 18, 2026Fresenius Kabi5 products

  • Asteria Health estradiol and testosterone pellets recalled for metal risk

    Asteria Health is recalling 25 sterile pellet products, all sold under the Asteria Health name, for possible metal particles. The products are estradiol and testosterone pellets, including some that also contain anastrozole or triamcinolone acetonide. No injuries have been reported.

    ModerateFDAFeb 18, 2026Asteria Health25 products

  • Unichem Pharmaceuticals doxazosin tablets recalled for wrong imprint

    Unichem Pharmaceuticals distributed 60,000 tablets of Doxazosin 4 mg with incorrect imprinting on the tablets themselves. This labeling error could cause confusion about the medication's identity and strength. The affected lot is GDSH25006, which expires in August 2027.

    ModerateFDAFeb 18, 2026Unichem Pharmaceuticals

  • Pro Numb tattoo numbing sprays recalled for manufacturing quality issues

    Pro Numb is recalling two tattoo numbing sprays because they were made in ways that did not meet FDA manufacturing standards. The recall covers Pro Numb Tattoo Numbing Spray 5% Lidocaine and Pro Numb Tattoo Numbing Spray For Sensitive Skin 4% Lidocaine, sold nationwide in the USA. No injuries have been reported.

    ModerateFDAFeb 18, 2026Pro Numb2 products

  • Sun Pharmaceutical diclofenac sodium gel recalled for failed viscosity specifications

    Sun Pharmaceutical is recalling one lot of Diclofenac Sodium Topical Gel, 3% (Lot #AD92721, expiring 3/31/2027) because the gel's thickness is slightly lower than required specifications. The product was distributed nationwide and is sold by prescription only.

    ModerateFDAFeb 11, 2026Sun Pharmaceutical

  • Rheumacare capsules recalled for lead found in product

    Rheumacare capsules manufactured by Virgo UAP Pharma in India were found to contain lead due to manufacturing defects. The affected product is a 30-count bottle with lot numbers CAM040 (expires 06/30/2029) or CAL079-N (expires 09/30/2028). Only 4 bottles were distributed to a customer in New York.

    SeriousFDAFeb 11, 2026Handelnine Global

  • Granules trazodone 50 mg recalled for foreign tablets

    Granules Pharmaceuticals is recalling certain bottles of trazodone 50 mg because some bottles may contain foreign tablets or capsules mixed in. This affects 71,424 bottles with batch number 6160008A and an expiration date of 12/31/2026. No injuries have been reported.

    ModerateFDAFeb 11, 2026Granules

  • Green Lumber Natural Fuel For Men recalled for containing tadalafil

    Green Lumber Natural Fuel For Men capsules were sold as a supplement but contain tadalafil, a prescription medication approved only for treating erectile dysfunction and certain heart conditions. The product was marketed and sold without FDA approval and without listing tadalafil on the label. Tadalafil can cause serious side effects, especially in people taking certain other medications or with certain health conditions.

    SeriousFDAFeb 11, 2026Green Lumber

  • Unichem bisoprolol and hydrochlorothiazide tablets recalled for impurity levels

    Unichem Pharmaceuticals is recalling one lot of bisoprolol fumarate and hydrochlorothiazide tablets (2.5 mg/6.25 mg) because they contain higher-than-allowed levels of N-Nitroso Bisoprolol, a potentially harmful impurity. The affected lot was manufactured in India and distributed nationwide.

    ModerateFDAFeb 11, 2026Unichem Pharmaceuticals

  • Stop using recalled Novadoz glycopyrrolate solution

    Novadoz Pharmaceuticals is recalling specific lots of glycopyrrolate oral solution (1 mg/5 mL) because the medication failed quality testing for impurities and degradation. The affected lots may not meet safety and effectiveness standards. Three lots are involved, with expiration dates between April and May 2027.

    ModerateFDAFeb 4, 2026Novadoz

  • Greenstone methylprednisolone Dosepak recalled for incorrect dosing information

    Greenstone LLC is recalling methylprednisolone 4 mg Dosepak tablets (Lot #LG7675, expiring November 2026) because the blister foil is oriented incorrectly. This misalignment can make the dosing directions on the foil confusing or unclear, which could lead to taking the wrong dose.

    ModerateFDAFeb 4, 2026Greenstone

  • INON ACE antacid tablets recalled for failed disintegration specifications

    Some bottles of INON ACE antacid tablets are dissolving more slowly than they should in your stomach. This means the medication may not work as intended. The affected bottles were distributed in California and Hawaii.

    ModerateFDAFeb 4, 2026Sato Pharmaceutical

  • parodontax mouthwash recalled for possible missing expiration dates

    Some bottles of Parodontax Active Gum Health mouthwash (mint, 16.9 FL OZ) may be missing or have illegible lot and expiration date codes. This makes it impossible to know when the product expires. The affected lot is #0665363 with an expiration date of 08/31/2027.

    FDAFeb 4, 2026Haleon

  • Stop using Baxter Sterile Water for Irrigation

    Baxter Healthcare's Sterile Water for Irrigation 250 mL bottles may contain small plastic particles that came loose from the bottle rim and entered the solution. This affects lot G171359 with an expiration date of 05/31/2027. No injuries have been reported.

    ModerateFDAFeb 4, 2026Baxter

  • Zydus icosapent ethyl capsules recalled for subpotency

    Zydus Pharmaceuticals is recalling Icosapent Ethyl 1-gram capsules because some bottles may contain capsules that have lost potency (strength) due to leakage and oxidation. This means the medication may not work as intended. The recall affects specific lot numbers expiring in February and April 2027.

    ModerateFDAJan 28, 2026Zydus

  • Stop using Specialty Process Labs Thyroid USP

    Specialty Process Labs is recalling one lot of Thyroid, USP (an active pharmaceutical ingredient used in manufacturing) because it does not meet strength standards. The affected lot may contain less active ingredient than labeled, which could affect the potency of products made with it.

    ModerateFDAJan 28, 2026Specialty Process Labs

  • Graviti furosemide tablets recalled for foreign substance

    Rising Pharmaceuticals is recalling Furosemide Tablets, USP 40 mg (a water pill used to treat swelling and high blood pressure) because some bottles may contain a foreign substance. The affected lot is FUB125042G with an expiration date of May 2027. This recall affects 4,212 bottles distributed nationwide.

    ModerateFDAJan 28, 2026Graviti Pharmaceuticals

  • Cipla diclofenac sodium gel recalled for failed pH specifications

    Cipla USA is recalling Diclofenac Sodium Topical Gel 1% (batch XHBG, expiring 08/31/2027) because it failed to meet required pH specifications during quality testing. The gel may not work as intended or could cause skin irritation. No injuries have been reported so far.

    ModerateFDAJan 28, 2026Cipla

  • Stop using Cipla Lanreotide Injection

    Cipla USA is recalling certain pre-filled syringes of Lanreotide Injection 120 mg because they may contain particulate matter (small particles) in the solution. The affected syringes have specific lot numbers and expiration dates between October 2026 and March 2027. No injuries have been reported so far.

    ModerateFDAJan 21, 2026Cipla

  • Advil, Tylenol and more OTC medicines recalled for rodent exposure

    Gold Star Distribution is recalling 27 over-the-counter products, including pain relievers, cold and flu medicines, antacids, cough drops, skin and lip care, petroleum jelly, rubbing alcohol and mouthwash. The products were stored or distributed from a facility with insanitary conditions, including rodent exposure and activity. No injuries have been reported.

    ModerateFDAJan 21, 2026Gold Star Distribution27 products

Explore other recall topics